Life Science


We have sold the Advanced Genetic Engineering (SAGE®) Labs business to a leading Life Sciences private equity firm.

We retain the CompoZr® Zinc Finger Nuclease (ZFN) custom cell engineering technology license. A supply agreement with the Buyer will enable access to this innovative platform for the development of research animal models.